Table 1.
Gene | Baseline visit; N = 461 (95% CI) | Dropouts; N = 270 (95% CI) | Adherent; N = 191 (95% CI) |
---|---|---|---|
CYP2D6 | |||
PMs | |||
*3/*4 | 0.009 (0.003–0.022) | 0.007 (0.002–0.027) | 0.010 (0.003–0.037) |
*4/*4 | 0.039 (0.025–0.061) | 0.037 (0.020–0.067) | 0.042 (0.021–0.080) |
*4/*4xN | 0.002 (0.000–0.012) | 0.004 (0.001–0.021) | NF |
*4/*5 | 0.022 (0.012–0.039) | 0.022 (0.010–0.048) | 0.021 (0.008–0.053) |
*4/*10 | 0.002 (0.000–0.012) | 0.004 (0.001–0.021) | NF |
*5/*5 | 0.004 (0.001–0.016) | 0.004 (0.001–0.021) | 0.005 (0.001–0.029) |
*5/*6 | 0.002 (0.000–0.012) | NF | 0.005 (0.001–0.029) |
NMs | |||
wt/wt | 0.518 (0.473–0.564) | 0.507 (0.448–0.566) | 0.534 (0.463–0.603) |
wt/*3 | 0.017 (0.009–0.034) | 0.015 (0.006–0.038) | 0.021 (0.008–0.053) |
wt/*4 | 0.215 (0.180–0.254) | 0.219 (0.173–0.272) | 0.209 (0.158–0.273) |
wt/*4xN | 0.004 (0.001–0.016) | 0.007 (0.002–0.027) | NF |
wt/*5 | 0.050 (0.033–0.074) | 0.059 (0.037–0.094) | 0.037 (0.018–0.074) |
wt/*6 | 0.019 (0.010–0.037) | 0.026 (0.013–0.053) | 0.010 (0.003–0.037) |
wt/*10 | 0.024 (0.013–0.042) | 0.030 (0.015–0.057) | 0.016 (0.005–0.045) |
wtx2/*3 | 0.002 (0.000–0.012) | 0.004 (0.001–0.021) | NF |
wtx2/*4 | 0.015 (0.007–0.031) | 0.004 (0.001–0.021) | 0.031 (0.014–0.067) |
wtx2/*10 | 0.002 (0.000–0.012) | 0.004 (0.001–0.021) | NF |
UMs | |||
wt/wtxN | 0.052 (0.035–0.076) | 0.048 (0.028–0.081) | 0.058 (0.032–0.100) |
CYP2C19 | |||
PMs | |||
*2/*2 | 0.0152 (0.007–0.031) | 0.019 (0.008–0.043) | 0.010 (0.003–0.037) |
NMs | |||
wt/*2 | 0.200 (0.166–0.238) | 0.189 (0.147–0.240) | 0.215 (0.162–0.278) |
wt/wt | 0.427 (0.383–0.473) | 0.437 (0.379–0.497) | 0.414 (0.346–0.484) |
*2/*17 | 0.089 (0.066–0.118) | 0.089 (0.060–0.129) | 0.089 (0.056–0.138) |
UMs | |||
wt/*17 | 0.252 (0.214–0.293) | 0.256 (0.207–0.311) | 0.246 (0.190–0.312) |
*17/*17 | 0.017 (0.009–0.034) | 0.011 (0.004–0.032) | 0.026 (0.011–0.060) |
PMs poor metabolizers (AS = 0), NM normal metabolizers (1 ≤ AS ≤ 2), UMs ultrarrapid metabolizers (AS > 2), NF not found.